Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Differential Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Interferon γ in Mast Cells and Epithelial Cells

Marianna Kulka, Rene Dery, Drew Nahirney, Marek Duszyk and A. Dean Befus
Journal of Pharmacology and Experimental Therapeutics November 2005, 315 (2) 563-570; DOI: https://doi.org/10.1124/jpet.105.087528
Marianna Kulka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rene Dery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Drew Nahirney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marek Duszyk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Dean Befus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-dependent chloride channel in epithelial cells; recently, we identified it in mast cells. Previous work that we confirmed showed that interferon γ (IFNγ) down-regulated CFTR expression in epithelial cells (T84), but by contrast, we found that IFNγ up-regulated CFTR mRNA and protein expression in rat and human mast cells. IFNγ up-regulation of CFTR in mast cells was inhibited by p38 and extracellular signal-regulated kinase (ERK) kinase inhibitors but not a Janus tyrosine kinase (JAK)2 inhibitor, whereas in T84 cells IFNγ-mediated down-regulation of CFTR was JAK2-dependent and ERK- and p38-independent. Furthermore, IFNγ down-regulation of CFTR in T84 epithelial cells was STAT1-dependent, but up-regulation of CFTR in mast cells was STAT1-independent. Thus, differential regulatory pathways of CFTR expression in mast cells and epithelial cells exist that depend upon either p38/ERK or JAK/STAT pathways, respectively. Surprisingly, IFNγ treatment of mast cells inhibited Cl- efflux, in contrast to up-regulation of CFTR/mRNA and protein expression. However, down-regulation of Cl- flux correlated with IFNγ-mediated inhibition of mediator secretion. This and other work suggests that the effect of IFNγ on CFTR expression in mast cells is important for their function.

Footnotes

  • This work was funded by grants to A.D.B. from the Canadian Institutes of Health Research (CIHR) and to M.D. from the Canadian Cystic Fibrosis Foundation. M.K. was supported by a student voucher from CIHR.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • doi:10.1124/jpet.105.087528.

  • ABBREVIATIONS: CFTR, cystic fibrosis transmembrane conductance regulator; PMC, rat peritoneal mast cell(s); ClC, voltage-gated Cl- channel; IFN, interferon; JAK, Janus tyrosine kinase; STAT, signal transduction and activator of transcription; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; TNF, tumor necrosis factor; AG-490, α-cyano-(3,4-dihydroxy)-N-benzylcinnamide tyrphostin B42; SB202190, C20H14FN3O; U0126, 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)-butadiene); PMA, phorbol 12-myristate 13-acetate; HTB, HEPES Tyrode's buffer; MC, mast cell; RCMC, rat cultured mast cell(s); FBS, fetal bovine serum; LAD2, Laboratory of Allergic Diseases mast cell line 2; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; JNK, c-Jun NH2-terminal kinase; FAM, 6-carboxyfluorescein; BSA, bovine serum albumin; PCR, polymerase chain reaction; MQAE, N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bromide; IL, interleukin.

  • ↵1 Current address: Allergy-Immunology Division, Feinberg School of Medicine, Northwestern University, Chicago, IL.

    • Received April 5, 2005.
    • Accepted July 26, 2005.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 377 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 377, Issue 2
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differential Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Interferon γ in Mast Cells and Epithelial Cells
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Differential Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Interferon γ in Mast Cells and Epithelial Cells

Marianna Kulka, Rene Dery, Drew Nahirney, Marek Duszyk and A. Dean Befus
Journal of Pharmacology and Experimental Therapeutics November 1, 2005, 315 (2) 563-570; DOI: https://doi.org/10.1124/jpet.105.087528

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCELLULAR AND MOLECULAR

Differential Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Interferon γ in Mast Cells and Epithelial Cells

Marianna Kulka, Rene Dery, Drew Nahirney, Marek Duszyk and A. Dean Befus
Journal of Pharmacology and Experimental Therapeutics November 1, 2005, 315 (2) 563-570; DOI: https://doi.org/10.1124/jpet.105.087528
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PARPi with vitamin C, decitabine or azacitidine for APL.
  • Circ-KRT6C/miR-485-3p/PDL1 axis in colorectal cancer.
  • Increased IL-10 by KCa3.1 Inhibition in Treg Cells
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics